Recruiting

Observational Study

Sponsor:

Brooklyn Clinical Research

Code:

NCT06412536

Conditions

Cardiovascular Diseases

Obesity

PreDiabetes

Diabetes Type 2

Metabolic Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Blood work

Study Details

Brief summary:

SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.

Conditions

Cardiovascular Diseases

Obesity

PreDiabetes

Diabetes Type 2

Metabolic Syndrome

Study ID

NCT06412536

Start date

May 30, 2024

Status verified date

May, 2024

Completion date

Apr 17, 2029

Anticipated

Primary completion date

Apr 10, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
2. Participant is at least 18 years old.

Exclusion Criteria:

1. Participant is pregnant, breast-feeding, or planning to become pregnant.
2. History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
3. Moderate or severe substance use disorder within 90 days prior to screen
4. Any condition that in the investigator's opinion makes a participant unsuitable for the study.
5. Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Blood work

Blood work on some participants to review eligibility for future clinical trials

Primary outcome measure

  • Number of participants who are interested in industry-sponsored clinical research [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Ammara Mushtaq, MD

929-203-5879amushtaq@brooklynclinicalresearch.com

Katherine Azer, MS

929-332-7848kazer@brooklynclinicalresearch.com

Locations

Brooklyn Clinical Research

Recruiting

Brooklyn, New York, United States, 11226

Contacts

Ammara Mushtaq, MD

929-203-5879amushtaq@brooklynclinicalresearch.com

Principal Investigator:

Ammara Mushtaq, MD

More Information

Sponsor

Brooklyn Clinical Research

Last update posted

Jun 11, 2024

Last verified

May, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Brooklyn Clinical Research on 2024-06-11.